Effect of botulinum toxin type A (Dysport®) injection combined with rehabilitation on improving the dynamic spastic equinus foot in children with spastic cerebral palsy

  • Nguyen Van Tung 108 Military Central Hospital

Main Article Content

Abstract

Objective: To evaluate the efficacy of botulinum toxin type A (BTA) injection in combination with rehabilitation on improving the dynamic spastic equinus foot in children with spastic cerebral palsy. Subject and method: Longitudinal interventional study with a control group. 140 eligible children with spastic cerebral palsy from 2 to 12 years old who were recruited from the Rehabilitation Department of National Children’s Hospital from December 2015 to December 2017. Result: After 12 months of the treatment, the mean MAS scores of the gastrocnemius-soleus of the intervention group decreased by 1.39 ± 0.63 (p<0.01), and the passive ankle range of motion (ankle-PROM) was increased by 16.66 ± 11.99° (p<0.01), while the mean MAS scores of the control group decreased by 0.15 ± 0.34° (p<0.01), and ankle-PROM was increased by 3.10 ± 7.38° (p<0.01). The mean difference of mean MAS scores at 12 months after treating between both groups was -1.07 (p<0.01), and the mean difference of mean ankle-PROM was 11.69° (p<0.01). Conclusion: Botulinum toxin type A (Dysport®) - injection combined with rehabilitation improved muscles tone, increasing passive ankle range of motion, and improving on lower limb motor function in children with spastic cerebral palsy.


Keywords: Spastic cerebral palsy, botulinum toxin type A, spastic equinus foot.

Article Details

References

1. Trịnh Quang Dũng, Nguyễn Hữu Chút (2014) Đánh giá kết quả phục hồi chức năng bại não thể co cứng bằng tiêm Dysport (Botulinum Toxin Type A) và các biện pháp phối hợp. Tạp chí Y học Thực hành 912: 58- 61.
2. Koman LA et al (1993) Management of cere-bral palsy with botulinum-A toxin: Preliminary investigation. J Pediatr Orthop 13(4): 489-495.
3. Bohannon RW and MB Smith (1987) Interrater reliability of a modified Ashworth scale of mus-cle spasticity. Phys Ther 67(2): 206-207.
4. Camargo CHF et al (2009) Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy. Arquivos de Neuro-Psiquiatria 67: 62-68.
5. Joung Lee S et al (2011) The effect and com-plication of botulinum toxin type A injection with serial casting for the treatment of spastic equinus foot. Ann Rehabil Med. 35(3): 344-353.
6. Ackman JD et al (2005) Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 47(9): 620-627.
7. Tedroff K et al (2009) Long-term effects of botulinum toxin A in children with cerebral pal-sy. Dev Med Child Neurol. 51(2): 120-127.
8. Samizadeh S and K De Boulle (2018) Botuli-num neurotoxin formulations: Overcoming the confusion. Clin Cosmet Investig Dermatol 11: 273-287.
9. Koog YH and BI Min (2010) Effects of botuli-num toxin A on calf muscles in children with cerebral palsy: A systematic review. Clin Re-habil 24(8): 685-700.
10. Bottos M et al (2003) Botulinum toxin with and without casting in ambulant children with spas-tic diplegia: A clinical and functional assess-ment. Dev Med Child Neurol 45(11): 758-762.